Pegaptanib sodium for the treatment of neovascular age-related macular degeneration: A review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pegaptanib sodium for the treatment of neovascular age-related macular degeneration: A review

Published:2006-01 Issue:1 Volume:28 Page:36-44
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Kourlas Helen,Schiller Daryl S.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference30 articles.

2. Current concepts in the pathogenesis of agerelated macular degeneration;Zarbin;Arch Ophthalmol,2004

3. Age-related macular degeneration;Arroyo,2005

4. Neovascular age-related macular degeneration;Lois;Comp Ophthalmol Update,2004

5. Eyetech and Pfizer announce FDA approval of Macugen® for treatment of neovascular (wet) age-related macular degeneration [press release],2004

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Application of Aptamer and Research Progress in Liver Disease;Molecular Biotechnology;2024-02-02

2. Recent advances of anti-angiogenic inhibitors targeting VEGF/VEGFR axis;Frontiers in Pharmacology;2024-01-04

3. Recent applications of RNA therapeutic in clinics;Progress in Molecular Biology and Translational Science;2024

4. RNA and nanocarriers: next generation drug and delivery platform take center stage;Trends in Biotechnology;2023-03

5. Ocular Drug Delivery: a Comprehensive Review;AAPS PharmSciTech;2023-02-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP